Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in Cervical Cancer
NCT00924066Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Nov 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in Cervical Cancer (CC), sponsored by National Cancer Institute. Started Nov 2008; status: terminated.
02
Drugs
ixabepilone
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00924066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924066.